MLYS
Mineralys Therapeutics, Inc.Company with tickers: MLYS
CIK
1933414
CUSIP
603170101
Shares Outstanding
82,498,101
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-18 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-05-18 | Rodman David Malcom | Chief Medical Officer | Sell | 417 |
| 2026-05-18 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-05-13 | Rodman David Malcom | Chief Medical Officer | Sell | 14,056 |
| 2026-05-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,166 |
| 2026-05-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,541 |
| 2026-05-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,541 |
| 2026-05-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,166 |
| 2026-05-12 | Rodman David Malcom | Chief Medical Officer | Sell | 6,348 |
| 2026-05-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,348 |
| 2026-05-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,348 |
| 2026-05-11 | Rodman David Malcom | Chief Medical Officer | Convert | 2,171 |
| 2026-05-11 | Rodman David Malcom | Chief Medical Officer | Sell | 2,171 |
| 2026-05-11 | Rodman David Malcom | Chief Medical Officer | Convert | 2,171 |
| 2026-04-17 | Rodman David Malcom | Chief Medical Officer | Convert | 416 |
| 2026-04-17 | Rodman David Malcom | Chief Medical Officer | Sell | 416 |
| 2026-04-17 | Rodman David Malcom | Chief Medical Officer | Convert | 416 |
| 2026-04-15 | Rodman David Malcom | Chief Medical Officer | Sell | 6,348 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 6,349 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Sell | 14,058 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,542 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 6,349 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,167 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,167 |
| 2026-04-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,542 |
| 2026-04-13 | Congleton Jon | Director, Chief Executive Officer | Sell | 15,730 |
| 2026-04-09 | Rodman David Malcom | Chief Medical Officer | Convert | 2,170 |
| 2026-04-09 | Rodman David Malcom | Chief Medical Officer | Sell | 2,170 |
| 2026-04-09 | Rodman David Malcom | Chief Medical Officer | Convert | 2,170 |
| 2026-03-31 | Karydas Daphne | Director | Convert | 3,000 |
| 2026-03-31 | Karydas Daphne | Director | Sell | 3,000 |
| 2026-03-31 | Karydas Daphne | Director | Convert | 3,000 |
| 2026-03-31 | Congleton Jon | Director, Chief Executive Officer | Sell | 453 |
| 2026-03-31 | Congleton Jon | Director, Chief Executive Officer | Sell | 19,364 |
| 2026-03-31 | Congleton Jon | Director, Chief Executive Officer | Sell | 55,183 |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 58,300 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,867,229 |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 310,700 |
| 2026-03-17 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-03-17 | Rodman David Malcom | Chief Medical Officer | Sell | 417 |
| 2026-03-17 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,167 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,167 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Sell | 253 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Sell | 3,079 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Sell | 10,726 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,542 |
| 2026-03-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,542 |
| 2026-03-12 | Rodman David Malcom | Chief Medical Officer | Sell | 6,348 |
| 2026-03-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,348 |
| 2026-03-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,348 |
| 2026-03-09 | Rodman David Malcom | Chief Medical Officer | Convert | 2,171 |
| 2026-03-09 | Rodman David Malcom | Chief Medical Officer | Sell | 2,171 |
| 2026-03-09 | Rodman David Malcom | Chief Medical Officer | Convert | 2,171 |
| 2026-03-04 | Warren Eric | Chief Commercial Officer | Other | 0 |
| 2026-03-04 | Warren Eric | Chief Commercial Officer | Other | 38,400 |
| 2026-03-04 | Warren Eric | Chief Commercial Officer | Other | 0 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 6,200 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 1,867,229 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. | Director | Award | 8,300 |
| 2026-02-19 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 5,456,521 |
| 2026-02-19 | Congleton Jon | Director, Chief Executive Officer | Award | 140,900 |
| 2026-02-19 | Congleton Jon | Director, Chief Executive Officer | Award | 187,900 |
| 2026-02-19 | SBLENDORIO GLENN | Director | Award | 6,200 |
| 2026-02-19 | SBLENDORIO GLENN | Director | Award | 8,300 |
| 2026-02-19 | Gold Alexander M | Director | Award | 6,200 |
| 2026-02-19 | Gold Alexander M | Director | Award | 8,300 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Award | 6,200 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Other | 6,200 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Other | 8,300 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Other | 6,200 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Award | 8,300 |
| 2026-02-19 | Slingsby Brian Taylor | Director, 10% Owner | Other | 8,300 |
| 2026-02-19 | AKKARAJU SRINIVAS | Director, 10% Owner | Other | 5,871,018 |
| 2026-02-19 | AKKARAJU SRINIVAS | Director, 10% Owner | Award | 6,200 |
| 2026-02-19 | AKKARAJU SRINIVAS | Director, 10% Owner | Award | 8,300 |
| 2026-02-19 | Karydas Daphne | Director | Award | 8,300 |
| 2026-02-19 | Karydas Daphne | Director | Award | 6,200 |
| 2026-02-19 | DiRocco Derek | Director | Award | 6,200 |
| 2026-02-19 | DiRocco Derek | Director | Award | 8,300 |
| 2026-02-19 | Rodman David Malcom | Chief Medical Officer | Award | 51,300 |
| 2026-02-19 | Rodman David Malcom | Chief Medical Officer | Award | 38,400 |
| 2026-02-19 | Levy Adam Scott | CFO and Secretary | Award | 53,300 |
| 2026-02-19 | Levy Adam Scott | CFO and Secretary | Award | 39,900 |
| 2026-02-17 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-02-17 | Rodman David Malcom | Chief Medical Officer | Convert | 417 |
| 2026-02-17 | Rodman David Malcom | Chief Medical Officer | Sell | 417 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Sell | 4,166 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,541 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Sell | 3,541 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,166 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Convert | 3,541 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Convert | 4,166 |
| 2026-02-13 | Rodman David Malcom | Chief Medical Officer | Sell | 6,348 |
| 2026-02-12 | Rodman David Malcom | Chief Medical Officer | Sell | 521 |
| 2026-02-12 | Rodman David Malcom | Chief Medical Officer | Sell | 5,828 |
| 2026-02-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,349 |
| 2026-02-12 | Rodman David Malcom | Chief Medical Officer | Convert | 6,349 |
| 2026-02-09 | Rodman David Malcom | Chief Medical Officer | Convert | 2,171 |
| 2026-02-09 | Rodman David Malcom | Chief Medical Officer | Sell | 2,171 |